Cited by 89Protease and Inhibitor MechanismsSarcoma Diagnosis and TreatmentTGF-β signaling in diseases

MMP14 in sarcoma: a regulator of tumor microenvironment communication in connective tissues

Open access
Gonzalez-Molina, Jordi, Gramolelli, Silvia, Liao, Zehuan, Carlson, Joseph W., Ojala, Päivi M., Lehti, Kaisa·2019·Cells

Abstract

Sarcomas are deadly malignant tumors of mesenchymal origin occurring at all ages. The expression and function of the membrane-type matrix metalloproteinase MMP14 is closely related to the mesenchymal cell phenotype, and it is highly expressed in most sarcomas. MMP14 regulates the activity of multiple extracellular and plasma membrane proteins, influencing cell–cell and cell–extracellular matrix (ECM) communication. This regulation mediates processes such as ECM degradation and remodeling, cell invasion, and cancer metastasis. Thus, a comprehensive understanding of the biology of MMP14 in sarcomas will shed light on the mechanisms controlling the key processes in these diseases. Here, we provide an overview of the function and regulation of MMP14 and we discuss their relationship with clinical and pre-clinical MMP14 data in both adult and childhood sarcomas.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells8090991

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Adverse clinical cancer outcomes are reported to be relevant to sarcopenic obesity, especially with respect to dose-limiting toxicity, surgical complications, physical disability, and shorter survival.

    “Moreover, adverse clinical cancer outcomes reported to be relevant to SO, especially with respect to dose-limiting toxicity, surgical complications, physical disability, and shorter survival (59–61).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 199 · Cited by 89

Authors
Gonzalez-Molina, J., Gramolelli, S., Liao, Z., Carlson, J. W., Ojala, P. M., & Lehti, K.
Affiliations
  • Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 17177 Stockholm, Sweden
  • University of Helsinki (FI)
  • Nanyang Technological University (SG)
  • Karolinska Institutet (SE)
Corresponding author
Lehti, Kaisa
Venue
Cells
Publisher
MDPI AG
Published
2019-08-28
Volume
8
Issue
9
Pages
991
ISSN
2073-4409 (ISSN-L)
OpenAlex
W2970922664
Cited by
89
References
199
Citations by year
2026: 7 · 2025: 13 · 2024: 8 · 2023: 17 · 2022: 12 · 2021: 18 · 2020: 11 · 2019: 3
FWCI
1.05
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DR-NTU (Nanyang Technological University) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Cancerfonden
  • Karolinska Institutet
  • Vetenskapsrådet
  • Sigrid Juséliuksen Säätiö
  • Barncancerfonden
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
MMP-14, membrane-type matrix metalloproteinases, sarcoma, tumor microenvironment, extracellular matrix remodeling, extracellular matrix degradation, cell invasion, metastasis, mesenchymal phenotype, pediatric sarcoma, connective tissue
MeSH terms
Adult, Cell Communication, Child, Connective Tissue, Extracellular Matrix, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Sarcoma, Gene Expression Regulation, Neoplastic, Matrix Metalloproteinase 14, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review